Global Inactivated Influenza Virus Vaccine Production, Demand and Key Producers, 2022-2028
This report studies the global Inactivated Influenza Virus Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inactivated Influenza Virus Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Influenza Virus Vaccine that contribute to its increasing demand across many markets.
The global Inactivated Influenza Virus Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Inactivated Influenza Virus Vaccine total production and demand, 2017-2028, (K Units)
Global Inactivated Influenza Virus Vaccine total production value, 2017-2028, (USD Million)
Global Inactivated Influenza Virus Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Inactivated Influenza Virus Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Inactivated Influenza Virus Vaccine domestic production, consumption, key domestic manufacturers and share
Global Inactivated Influenza Virus Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Inactivated Influenza Virus Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Inactivated Influenza Virus Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Inactivated Influenza Virus Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Inactivated Influenza Virus Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Influenza Virus Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Inactivated Influenza Virus Vaccine Market, By Region:
1. How big is the global Inactivated Influenza Virus Vaccine market?
2. What is the demand of the global Inactivated Influenza Virus Vaccine market?
3. What is the year over year growth of the global Inactivated Influenza Virus Vaccine market?
4. What is the production and production value of the global Inactivated Influenza Virus Vaccine market?
5. Who are the key producers in the global Inactivated Influenza Virus Vaccine market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Inactivated Influenza Virus Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Influenza Virus Vaccine that contribute to its increasing demand across many markets.
The global Inactivated Influenza Virus Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Inactivated Influenza Virus Vaccine total production and demand, 2017-2028, (K Units)
Global Inactivated Influenza Virus Vaccine total production value, 2017-2028, (USD Million)
Global Inactivated Influenza Virus Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Inactivated Influenza Virus Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Inactivated Influenza Virus Vaccine domestic production, consumption, key domestic manufacturers and share
Global Inactivated Influenza Virus Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Inactivated Influenza Virus Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Inactivated Influenza Virus Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Inactivated Influenza Virus Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Inactivated Influenza Virus Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Influenza Virus Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Inactivated Influenza Virus Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Whole Virus Vaccine
- Subunit Vaccine
- Hospital
- Clinic
- CSL
- GSK
- Sanofi Pasteur
- Mylan
- AstraZeneca
- Pfizer
- Johnson & Johnson
- Jiangsu Jindik Biotechnology Co., Ltd
- Beijing Kexing Biological Products Co., Ltd
- Jiangsu Kangrun Biotechnology Co., Ltd
- Hualan Bio Vaccines Co., Ltd
- Dalian Yalifeng Biopharmaceutical Co., Ltd
- Shanghai Institute of Biological Products Co., Ltd
- Changchun Institute of Biological Products Co., Ltd
- Lanzhou Institute of Biological Products Co., Ltd
- Zhejiang Tian Yuan Biopharmaceutical Co., Ltd
- Emmi Chengxin Biopharmaceutical Co., Ltd
1. How big is the global Inactivated Influenza Virus Vaccine market?
2. What is the demand of the global Inactivated Influenza Virus Vaccine market?
3. What is the year over year growth of the global Inactivated Influenza Virus Vaccine market?
4. What is the production and production value of the global Inactivated Influenza Virus Vaccine market?
5. Who are the key producers in the global Inactivated Influenza Virus Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Inactivated Influenza Virus Vaccine Introduction
1.2 World Inactivated Influenza Virus Vaccine Supply & Forecast
1.2.1 World Inactivated Influenza Virus Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Inactivated Influenza Virus Vaccine Production (2017-2028)
1.2.3 World Inactivated Influenza Virus Vaccine Pricing Trends (2017-2028)
1.3 World Inactivated Influenza Virus Vaccine Production by Region
1.3.1 World Inactivated Influenza Virus Vaccine Production Value by Region (2017-2028)
1.3.2 World Inactivated Influenza Virus Vaccine Production by Region (2017-2028)
1.3.3 World Inactivated Influenza Virus Vaccine Average Price by Region (2017-2028)
1.3.4 North America Inactivated Influenza Virus Vaccine Production (2017-2028)
1.3.5 Europe Inactivated Influenza Virus Vaccine Production (2017-2028)
1.3.6 China Inactivated Influenza Virus Vaccine Production (2017-2028)
1.3.7 Japan Inactivated Influenza Virus Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inactivated Influenza Virus Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inactivated Influenza Virus Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Inactivated Influenza Virus Vaccine Demand (2017-2028)
2.2 World Inactivated Influenza Virus Vaccine Consumption by Region
2.2.1 World Inactivated Influenza Virus Vaccine Consumption by Region (2017-2022)
2.2.2 World Inactivated Influenza Virus Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.4 China Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.5 Europe Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.6 Japan Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.7 South Korea Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.8 ASEAN Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.9 India Inactivated Influenza Virus Vaccine Consumption (2017-2028)
3 WORLD INACTIVATED INFLUENZA VIRUS VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inactivated Influenza Virus Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Inactivated Influenza Virus Vaccine Production by Manufacturer (2017-2022)
3.3 World Inactivated Influenza Virus Vaccine Average Price by Manufacturer (2017-2022)
3.4 Inactivated Influenza Virus Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inactivated Influenza Virus Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inactivated Influenza Virus Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Inactivated Influenza Virus Vaccine in 2021
3.6 Inactivated Influenza Virus Vaccine Market: Overall Company Footprint Analysis
3.6.1 Inactivated Influenza Virus Vaccine Market: Region Footprint
3.6.2 Inactivated Influenza Virus Vaccine Market: Company Product Type Footprint
3.6.3 Inactivated Influenza Virus Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inactivated Influenza Virus Vaccine Production Value Comparison
4.1.1 United States VS China: Inactivated Influenza Virus Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Inactivated Influenza Virus Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Inactivated Influenza Virus Vaccine Production Comparison
4.2.1 United States VS China: Inactivated Influenza Virus Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Inactivated Influenza Virus Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Inactivated Influenza Virus Vaccine Consumption Comparison
4.3.1 United States VS China: Inactivated Influenza Virus Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Inactivated Influenza Virus Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Inactivated Influenza Virus Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Inactivated Influenza Virus Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Inactivated Influenza Virus Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Inactivated Influenza Virus Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Inactivated Influenza Virus Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Inactivated Influenza Virus Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Inactivated Influenza Virus Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Whole Virus Vaccine
5.2.2 Subunit Vaccine
5.3 Market Segment by Type
5.3.1 World Inactivated Influenza Virus Vaccine Production by Type (2017-2028)
5.3.2 World Inactivated Influenza Virus Vaccine Production Value by Type (2017-2028)
5.3.3 World Inactivated Influenza Virus Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Inactivated Influenza Virus Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Inactivated Influenza Virus Vaccine Production by Application (2017-2028)
6.3.2 World Inactivated Influenza Virus Vaccine Production Value by Application (2017-2028)
6.3.3 World Inactivated Influenza Virus Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 CSL
7.1.1 CSL Details
7.1.2 CSL Major Business
7.1.3 CSL Inactivated Influenza Virus Vaccine Product and Services
7.1.4 CSL Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 CSL Recent Developments/Updates
7.1.6 CSL Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Inactivated Influenza Virus Vaccine Product and Services
7.2.4 GSK Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Sanofi Pasteur
7.3.1 Sanofi Pasteur Details
7.3.2 Sanofi Pasteur Major Business
7.3.3 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product and Services
7.3.4 Sanofi Pasteur Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Sanofi Pasteur Recent Developments/Updates
7.3.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.4 Mylan
7.4.1 Mylan Details
7.4.2 Mylan Major Business
7.4.3 Mylan Inactivated Influenza Virus Vaccine Product and Services
7.4.4 Mylan Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Mylan Recent Developments/Updates
7.4.6 Mylan Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Inactivated Influenza Virus Vaccine Product and Services
7.5.4 AstraZeneca Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Inactivated Influenza Virus Vaccine Product and Services
7.6.4 Pfizer Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Details
7.7.2 Johnson & Johnson Major Business
7.7.3 Johnson & Johnson Inactivated Influenza Virus Vaccine Product and Services
7.7.4 Johnson & Johnson Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Johnson & Johnson Recent Developments/Updates
7.7.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.8 Jiangsu Jindik Biotechnology Co., Ltd
7.8.1 Jiangsu Jindik Biotechnology Co., Ltd Details
7.8.2 Jiangsu Jindik Biotechnology Co., Ltd Major Business
7.8.3 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.8.4 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Jiangsu Jindik Biotechnology Co., Ltd Recent Developments/Updates
7.8.6 Jiangsu Jindik Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.9 Beijing Kexing Biological Products Co., Ltd
7.9.1 Beijing Kexing Biological Products Co., Ltd Details
7.9.2 Beijing Kexing Biological Products Co., Ltd Major Business
7.9.3 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.9.4 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Beijing Kexing Biological Products Co., Ltd Recent Developments/Updates
7.9.6 Beijing Kexing Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.10 Jiangsu Kangrun Biotechnology Co., Ltd
7.10.1 Jiangsu Kangrun Biotechnology Co., Ltd Details
7.10.2 Jiangsu Kangrun Biotechnology Co., Ltd Major Business
7.10.3 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.10.4 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Jiangsu Kangrun Biotechnology Co., Ltd Recent Developments/Updates
7.10.6 Jiangsu Kangrun Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.11 Hualan Bio Vaccines Co., Ltd
7.11.1 Hualan Bio Vaccines Co., Ltd Details
7.11.2 Hualan Bio Vaccines Co., Ltd Major Business
7.11.3 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.11.4 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Hualan Bio Vaccines Co., Ltd Recent Developments/Updates
7.11.6 Hualan Bio Vaccines Co., Ltd Competitive Strengths & Weaknesses
7.12 Dalian Yalifeng Biopharmaceutical Co., Ltd
7.12.1 Dalian Yalifeng Biopharmaceutical Co., Ltd Details
7.12.2 Dalian Yalifeng Biopharmaceutical Co., Ltd Major Business
7.12.3 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.12.4 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Dalian Yalifeng Biopharmaceutical Co., Ltd Recent Developments/Updates
7.12.6 Dalian Yalifeng Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.13 Shanghai Institute of Biological Products Co., Ltd
7.13.1 Shanghai Institute of Biological Products Co., Ltd Details
7.13.2 Shanghai Institute of Biological Products Co., Ltd Major Business
7.13.3 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.13.4 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Shanghai Institute of Biological Products Co., Ltd Recent Developments/Updates
7.13.6 Shanghai Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.14 Changchun Institute of Biological Products Co., Ltd
7.14.1 Changchun Institute of Biological Products Co., Ltd Details
7.14.2 Changchun Institute of Biological Products Co., Ltd Major Business
7.14.3 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.14.4 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Changchun Institute of Biological Products Co., Ltd Recent Developments/Updates
7.14.6 Changchun Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.15 Lanzhou Institute of Biological Products Co., Ltd
7.15.1 Lanzhou Institute of Biological Products Co., Ltd Details
7.15.2 Lanzhou Institute of Biological Products Co., Ltd Major Business
7.15.3 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.15.4 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
7.15.6 Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.16 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd
7.16.1 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Details
7.16.2 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Major Business
7.16.3 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.16.4 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Recent Developments/Updates
7.16.6 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.17 Emmi Chengxin Biopharmaceutical Co., Ltd
7.17.1 Emmi Chengxin Biopharmaceutical Co., Ltd Details
7.17.2 Emmi Chengxin Biopharmaceutical Co., Ltd Major Business
7.17.3 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.17.4 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Emmi Chengxin Biopharmaceutical Co., Ltd Recent Developments/Updates
7.17.6 Emmi Chengxin Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Inactivated Influenza Virus Vaccine and Key Manufacturers
8.2 Inactivated Influenza Virus Vaccine Manufacturing Costs
8.3 Inactivated Influenza Virus Vaccine Production Process
8.4 Inactivated Influenza Virus Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Inactivated Influenza Virus Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Inactivated Influenza Virus Vaccine Typical Distributors
9.3 Inactivated Influenza Virus Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Inactivated Influenza Virus Vaccine Introduction
1.2 World Inactivated Influenza Virus Vaccine Supply & Forecast
1.2.1 World Inactivated Influenza Virus Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Inactivated Influenza Virus Vaccine Production (2017-2028)
1.2.3 World Inactivated Influenza Virus Vaccine Pricing Trends (2017-2028)
1.3 World Inactivated Influenza Virus Vaccine Production by Region
1.3.1 World Inactivated Influenza Virus Vaccine Production Value by Region (2017-2028)
1.3.2 World Inactivated Influenza Virus Vaccine Production by Region (2017-2028)
1.3.3 World Inactivated Influenza Virus Vaccine Average Price by Region (2017-2028)
1.3.4 North America Inactivated Influenza Virus Vaccine Production (2017-2028)
1.3.5 Europe Inactivated Influenza Virus Vaccine Production (2017-2028)
1.3.6 China Inactivated Influenza Virus Vaccine Production (2017-2028)
1.3.7 Japan Inactivated Influenza Virus Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inactivated Influenza Virus Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inactivated Influenza Virus Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Inactivated Influenza Virus Vaccine Demand (2017-2028)
2.2 World Inactivated Influenza Virus Vaccine Consumption by Region
2.2.1 World Inactivated Influenza Virus Vaccine Consumption by Region (2017-2022)
2.2.2 World Inactivated Influenza Virus Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.4 China Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.5 Europe Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.6 Japan Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.7 South Korea Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.8 ASEAN Inactivated Influenza Virus Vaccine Consumption (2017-2028)
2.9 India Inactivated Influenza Virus Vaccine Consumption (2017-2028)
3 WORLD INACTIVATED INFLUENZA VIRUS VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inactivated Influenza Virus Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Inactivated Influenza Virus Vaccine Production by Manufacturer (2017-2022)
3.3 World Inactivated Influenza Virus Vaccine Average Price by Manufacturer (2017-2022)
3.4 Inactivated Influenza Virus Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inactivated Influenza Virus Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inactivated Influenza Virus Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Inactivated Influenza Virus Vaccine in 2021
3.6 Inactivated Influenza Virus Vaccine Market: Overall Company Footprint Analysis
3.6.1 Inactivated Influenza Virus Vaccine Market: Region Footprint
3.6.2 Inactivated Influenza Virus Vaccine Market: Company Product Type Footprint
3.6.3 Inactivated Influenza Virus Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inactivated Influenza Virus Vaccine Production Value Comparison
4.1.1 United States VS China: Inactivated Influenza Virus Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Inactivated Influenza Virus Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Inactivated Influenza Virus Vaccine Production Comparison
4.2.1 United States VS China: Inactivated Influenza Virus Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Inactivated Influenza Virus Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Inactivated Influenza Virus Vaccine Consumption Comparison
4.3.1 United States VS China: Inactivated Influenza Virus Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Inactivated Influenza Virus Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Inactivated Influenza Virus Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Inactivated Influenza Virus Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Inactivated Influenza Virus Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Inactivated Influenza Virus Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Inactivated Influenza Virus Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Inactivated Influenza Virus Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Inactivated Influenza Virus Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Whole Virus Vaccine
5.2.2 Subunit Vaccine
5.3 Market Segment by Type
5.3.1 World Inactivated Influenza Virus Vaccine Production by Type (2017-2028)
5.3.2 World Inactivated Influenza Virus Vaccine Production Value by Type (2017-2028)
5.3.3 World Inactivated Influenza Virus Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Inactivated Influenza Virus Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Inactivated Influenza Virus Vaccine Production by Application (2017-2028)
6.3.2 World Inactivated Influenza Virus Vaccine Production Value by Application (2017-2028)
6.3.3 World Inactivated Influenza Virus Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 CSL
7.1.1 CSL Details
7.1.2 CSL Major Business
7.1.3 CSL Inactivated Influenza Virus Vaccine Product and Services
7.1.4 CSL Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 CSL Recent Developments/Updates
7.1.6 CSL Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Inactivated Influenza Virus Vaccine Product and Services
7.2.4 GSK Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Sanofi Pasteur
7.3.1 Sanofi Pasteur Details
7.3.2 Sanofi Pasteur Major Business
7.3.3 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product and Services
7.3.4 Sanofi Pasteur Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Sanofi Pasteur Recent Developments/Updates
7.3.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.4 Mylan
7.4.1 Mylan Details
7.4.2 Mylan Major Business
7.4.3 Mylan Inactivated Influenza Virus Vaccine Product and Services
7.4.4 Mylan Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Mylan Recent Developments/Updates
7.4.6 Mylan Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Inactivated Influenza Virus Vaccine Product and Services
7.5.4 AstraZeneca Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Inactivated Influenza Virus Vaccine Product and Services
7.6.4 Pfizer Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Details
7.7.2 Johnson & Johnson Major Business
7.7.3 Johnson & Johnson Inactivated Influenza Virus Vaccine Product and Services
7.7.4 Johnson & Johnson Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Johnson & Johnson Recent Developments/Updates
7.7.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.8 Jiangsu Jindik Biotechnology Co., Ltd
7.8.1 Jiangsu Jindik Biotechnology Co., Ltd Details
7.8.2 Jiangsu Jindik Biotechnology Co., Ltd Major Business
7.8.3 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.8.4 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Jiangsu Jindik Biotechnology Co., Ltd Recent Developments/Updates
7.8.6 Jiangsu Jindik Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.9 Beijing Kexing Biological Products Co., Ltd
7.9.1 Beijing Kexing Biological Products Co., Ltd Details
7.9.2 Beijing Kexing Biological Products Co., Ltd Major Business
7.9.3 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.9.4 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Beijing Kexing Biological Products Co., Ltd Recent Developments/Updates
7.9.6 Beijing Kexing Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.10 Jiangsu Kangrun Biotechnology Co., Ltd
7.10.1 Jiangsu Kangrun Biotechnology Co., Ltd Details
7.10.2 Jiangsu Kangrun Biotechnology Co., Ltd Major Business
7.10.3 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.10.4 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Jiangsu Kangrun Biotechnology Co., Ltd Recent Developments/Updates
7.10.6 Jiangsu Kangrun Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.11 Hualan Bio Vaccines Co., Ltd
7.11.1 Hualan Bio Vaccines Co., Ltd Details
7.11.2 Hualan Bio Vaccines Co., Ltd Major Business
7.11.3 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.11.4 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Hualan Bio Vaccines Co., Ltd Recent Developments/Updates
7.11.6 Hualan Bio Vaccines Co., Ltd Competitive Strengths & Weaknesses
7.12 Dalian Yalifeng Biopharmaceutical Co., Ltd
7.12.1 Dalian Yalifeng Biopharmaceutical Co., Ltd Details
7.12.2 Dalian Yalifeng Biopharmaceutical Co., Ltd Major Business
7.12.3 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.12.4 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Dalian Yalifeng Biopharmaceutical Co., Ltd Recent Developments/Updates
7.12.6 Dalian Yalifeng Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.13 Shanghai Institute of Biological Products Co., Ltd
7.13.1 Shanghai Institute of Biological Products Co., Ltd Details
7.13.2 Shanghai Institute of Biological Products Co., Ltd Major Business
7.13.3 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.13.4 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Shanghai Institute of Biological Products Co., Ltd Recent Developments/Updates
7.13.6 Shanghai Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.14 Changchun Institute of Biological Products Co., Ltd
7.14.1 Changchun Institute of Biological Products Co., Ltd Details
7.14.2 Changchun Institute of Biological Products Co., Ltd Major Business
7.14.3 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.14.4 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Changchun Institute of Biological Products Co., Ltd Recent Developments/Updates
7.14.6 Changchun Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.15 Lanzhou Institute of Biological Products Co., Ltd
7.15.1 Lanzhou Institute of Biological Products Co., Ltd Details
7.15.2 Lanzhou Institute of Biological Products Co., Ltd Major Business
7.15.3 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.15.4 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
7.15.6 Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.16 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd
7.16.1 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Details
7.16.2 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Major Business
7.16.3 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.16.4 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Recent Developments/Updates
7.16.6 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.17 Emmi Chengxin Biopharmaceutical Co., Ltd
7.17.1 Emmi Chengxin Biopharmaceutical Co., Ltd Details
7.17.2 Emmi Chengxin Biopharmaceutical Co., Ltd Major Business
7.17.3 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
7.17.4 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Emmi Chengxin Biopharmaceutical Co., Ltd Recent Developments/Updates
7.17.6 Emmi Chengxin Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Inactivated Influenza Virus Vaccine and Key Manufacturers
8.2 Inactivated Influenza Virus Vaccine Manufacturing Costs
8.3 Inactivated Influenza Virus Vaccine Production Process
8.4 Inactivated Influenza Virus Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Inactivated Influenza Virus Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Inactivated Influenza Virus Vaccine Typical Distributors
9.3 Inactivated Influenza Virus Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Inactivated Influenza Virus Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Inactivated Influenza Virus Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Inactivated Influenza Virus Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Inactivated Influenza Virus Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Inactivated Influenza Virus Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Inactivated Influenza Virus Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Inactivated Influenza Virus Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Inactivated Influenza Virus Vaccine Production Market Share by Region (2017-2022)
Table 9. World Inactivated Influenza Virus Vaccine Production Market Share by Region (2023-2028)
Table 10. World Inactivated Influenza Virus Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Inactivated Influenza Virus Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Inactivated Influenza Virus Vaccine Major Market Trends
Table 13. World Inactivated Influenza Virus Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Inactivated Influenza Virus Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Inactivated Influenza Virus Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Inactivated Influenza Virus Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Inactivated Influenza Virus Vaccine Producers in 2021
Table 18. World Inactivated Influenza Virus Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Inactivated Influenza Virus Vaccine Producers in 2021
Table 20. World Inactivated Influenza Virus Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Inactivated Influenza Virus Vaccine Company Evaluation Quadrant
Table 22. World Inactivated Influenza Virus Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Inactivated Influenza Virus Vaccine Production Site of Key Manufacturer
Table 24. Inactivated Influenza Virus Vaccine Market: Company Product Type Footprint
Table 25. Inactivated Influenza Virus Vaccine Market: Company Product Application Footprint
Table 26. Inactivated Influenza Virus Vaccine Competitive Factors
Table 27. Inactivated Influenza Virus Vaccine New Entrant and Capacity Expansion Plans
Table 28. Inactivated Influenza Virus Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Inactivated Influenza Virus Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Inactivated Influenza Virus Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Inactivated Influenza Virus Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Inactivated Influenza Virus Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Inactivated Influenza Virus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Inactivated Influenza Virus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Inactivated Influenza Virus Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Inactivated Influenza Virus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Inactivated Influenza Virus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Inactivated Influenza Virus Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Inactivated Influenza Virus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Inactivated Influenza Virus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Inactivated Influenza Virus Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Inactivated Influenza Virus Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Inactivated Influenza Virus Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Inactivated Influenza Virus Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Inactivated Influenza Virus Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Inactivated Influenza Virus Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Inactivated Influenza Virus Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Inactivated Influenza Virus Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Inactivated Influenza Virus Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Inactivated Influenza Virus Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Inactivated Influenza Virus Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Inactivated Influenza Virus Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Inactivated Influenza Virus Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Inactivated Influenza Virus Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. CSL Basic Information, Manufacturing Base and Competitors
Table 62. CSL Major Business
Table 63. CSL Inactivated Influenza Virus Vaccine Product and Services
Table 64. CSL Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. CSL Recent Developments/Updates
Table 66. CSL Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Inactivated Influenza Virus Vaccine Product and Services
Table 70. GSK Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Pasteur Major Business
Table 75. Sanofi Pasteur Inactivated Influenza Virus Vaccine Product and Services
Table 76. Sanofi Pasteur Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sanofi Pasteur Recent Developments/Updates
Table 78. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 79. Mylan Basic Information, Manufacturing Base and Competitors
Table 80. Mylan Major Business
Table 81. Mylan Inactivated Influenza Virus Vaccine Product and Services
Table 82. Mylan Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Mylan Recent Developments/Updates
Table 84. Mylan Competitive Strengths & Weaknesses
Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Major Business
Table 87. AstraZeneca Inactivated Influenza Virus Vaccine Product and Services
Table 88. AstraZeneca Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. AstraZeneca Recent Developments/Updates
Table 90. AstraZeneca Competitive Strengths & Weaknesses
Table 91. Pfizer Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer Major Business
Table 93. Pfizer Inactivated Influenza Virus Vaccine Product and Services
Table 94. Pfizer Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Pfizer Recent Developments/Updates
Table 96. Pfizer Competitive Strengths & Weaknesses
Table 97. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 98. Johnson & Johnson Major Business
Table 99. Johnson & Johnson Inactivated Influenza Virus Vaccine Product and Services
Table 100. Johnson & Johnson Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Johnson & Johnson Recent Developments/Updates
Table 102. Johnson & Johnson Competitive Strengths & Weaknesses
Table 103. Jiangsu Jindik Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Jiangsu Jindik Biotechnology Co., Ltd Major Business
Table 105. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 106. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Jiangsu Jindik Biotechnology Co., Ltd Recent Developments/Updates
Table 108. Jiangsu Jindik Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 109. Beijing Kexing Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Beijing Kexing Biological Products Co., Ltd Major Business
Table 111. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 112. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Beijing Kexing Biological Products Co., Ltd Recent Developments/Updates
Table 114. Beijing Kexing Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 115. Jiangsu Kangrun Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Jiangsu Kangrun Biotechnology Co., Ltd Major Business
Table 117. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 118. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Jiangsu Kangrun Biotechnology Co., Ltd Recent Developments/Updates
Table 120. Jiangsu Kangrun Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 121. Hualan Bio Vaccines Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Hualan Bio Vaccines Co., Ltd Major Business
Table 123. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 124. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Hualan Bio Vaccines Co., Ltd Recent Developments/Updates
Table 126. Hualan Bio Vaccines Co., Ltd Competitive Strengths & Weaknesses
Table 127. Dalian Yalifeng Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Dalian Yalifeng Biopharmaceutical Co., Ltd Major Business
Table 129. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 130. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Dalian Yalifeng Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 132. Dalian Yalifeng Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 133. Shanghai Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Shanghai Institute of Biological Products Co., Ltd Major Business
Table 135. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 136. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Shanghai Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 138. Shanghai Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 139. Changchun Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Changchun Institute of Biological Products Co., Ltd Major Business
Table 141. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 142. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Changchun Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 144. Changchun Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 145. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Lanzhou Institute of Biological Products Co., Ltd Major Business
Table 147. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 148. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 150. Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 151. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 152. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Major Business
Table 153. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 154. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 156. Emmi Chengxin Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 157. Emmi Chengxin Biopharmaceutical Co., Ltd Major Business
Table 158. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 159. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 160. Inactivated Influenza Virus Vaccine Raw Material
Table 161. Key Manufacturers of Inactivated Influenza Virus Vaccine Raw Materials
Table 162. Inactivated Influenza Virus Vaccine Typical Distributors
Table 163. Inactivated Influenza Virus Vaccine Typical Customers
Table 1. World Inactivated Influenza Virus Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Inactivated Influenza Virus Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Inactivated Influenza Virus Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Inactivated Influenza Virus Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Inactivated Influenza Virus Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Inactivated Influenza Virus Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Inactivated Influenza Virus Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Inactivated Influenza Virus Vaccine Production Market Share by Region (2017-2022)
Table 9. World Inactivated Influenza Virus Vaccine Production Market Share by Region (2023-2028)
Table 10. World Inactivated Influenza Virus Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Inactivated Influenza Virus Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Inactivated Influenza Virus Vaccine Major Market Trends
Table 13. World Inactivated Influenza Virus Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Inactivated Influenza Virus Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Inactivated Influenza Virus Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Inactivated Influenza Virus Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Inactivated Influenza Virus Vaccine Producers in 2021
Table 18. World Inactivated Influenza Virus Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Inactivated Influenza Virus Vaccine Producers in 2021
Table 20. World Inactivated Influenza Virus Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Inactivated Influenza Virus Vaccine Company Evaluation Quadrant
Table 22. World Inactivated Influenza Virus Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Inactivated Influenza Virus Vaccine Production Site of Key Manufacturer
Table 24. Inactivated Influenza Virus Vaccine Market: Company Product Type Footprint
Table 25. Inactivated Influenza Virus Vaccine Market: Company Product Application Footprint
Table 26. Inactivated Influenza Virus Vaccine Competitive Factors
Table 27. Inactivated Influenza Virus Vaccine New Entrant and Capacity Expansion Plans
Table 28. Inactivated Influenza Virus Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Inactivated Influenza Virus Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Inactivated Influenza Virus Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Inactivated Influenza Virus Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Inactivated Influenza Virus Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Inactivated Influenza Virus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Inactivated Influenza Virus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Inactivated Influenza Virus Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Inactivated Influenza Virus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Inactivated Influenza Virus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Inactivated Influenza Virus Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Inactivated Influenza Virus Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Inactivated Influenza Virus Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Inactivated Influenza Virus Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Inactivated Influenza Virus Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Inactivated Influenza Virus Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Inactivated Influenza Virus Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Inactivated Influenza Virus Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Inactivated Influenza Virus Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Inactivated Influenza Virus Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Inactivated Influenza Virus Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Inactivated Influenza Virus Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Inactivated Influenza Virus Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Inactivated Influenza Virus Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Inactivated Influenza Virus Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Inactivated Influenza Virus Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Inactivated Influenza Virus Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Inactivated Influenza Virus Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Inactivated Influenza Virus Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. CSL Basic Information, Manufacturing Base and Competitors
Table 62. CSL Major Business
Table 63. CSL Inactivated Influenza Virus Vaccine Product and Services
Table 64. CSL Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. CSL Recent Developments/Updates
Table 66. CSL Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Inactivated Influenza Virus Vaccine Product and Services
Table 70. GSK Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Pasteur Major Business
Table 75. Sanofi Pasteur Inactivated Influenza Virus Vaccine Product and Services
Table 76. Sanofi Pasteur Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sanofi Pasteur Recent Developments/Updates
Table 78. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 79. Mylan Basic Information, Manufacturing Base and Competitors
Table 80. Mylan Major Business
Table 81. Mylan Inactivated Influenza Virus Vaccine Product and Services
Table 82. Mylan Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Mylan Recent Developments/Updates
Table 84. Mylan Competitive Strengths & Weaknesses
Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Major Business
Table 87. AstraZeneca Inactivated Influenza Virus Vaccine Product and Services
Table 88. AstraZeneca Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. AstraZeneca Recent Developments/Updates
Table 90. AstraZeneca Competitive Strengths & Weaknesses
Table 91. Pfizer Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer Major Business
Table 93. Pfizer Inactivated Influenza Virus Vaccine Product and Services
Table 94. Pfizer Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Pfizer Recent Developments/Updates
Table 96. Pfizer Competitive Strengths & Weaknesses
Table 97. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 98. Johnson & Johnson Major Business
Table 99. Johnson & Johnson Inactivated Influenza Virus Vaccine Product and Services
Table 100. Johnson & Johnson Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Johnson & Johnson Recent Developments/Updates
Table 102. Johnson & Johnson Competitive Strengths & Weaknesses
Table 103. Jiangsu Jindik Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Jiangsu Jindik Biotechnology Co., Ltd Major Business
Table 105. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 106. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Jiangsu Jindik Biotechnology Co., Ltd Recent Developments/Updates
Table 108. Jiangsu Jindik Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 109. Beijing Kexing Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Beijing Kexing Biological Products Co., Ltd Major Business
Table 111. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 112. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Beijing Kexing Biological Products Co., Ltd Recent Developments/Updates
Table 114. Beijing Kexing Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 115. Jiangsu Kangrun Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Jiangsu Kangrun Biotechnology Co., Ltd Major Business
Table 117. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 118. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Jiangsu Kangrun Biotechnology Co., Ltd Recent Developments/Updates
Table 120. Jiangsu Kangrun Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 121. Hualan Bio Vaccines Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Hualan Bio Vaccines Co., Ltd Major Business
Table 123. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 124. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Hualan Bio Vaccines Co., Ltd Recent Developments/Updates
Table 126. Hualan Bio Vaccines Co., Ltd Competitive Strengths & Weaknesses
Table 127. Dalian Yalifeng Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Dalian Yalifeng Biopharmaceutical Co., Ltd Major Business
Table 129. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 130. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Dalian Yalifeng Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 132. Dalian Yalifeng Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 133. Shanghai Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Shanghai Institute of Biological Products Co., Ltd Major Business
Table 135. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 136. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Shanghai Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 138. Shanghai Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 139. Changchun Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Changchun Institute of Biological Products Co., Ltd Major Business
Table 141. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 142. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Changchun Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 144. Changchun Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 145. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Lanzhou Institute of Biological Products Co., Ltd Major Business
Table 147. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 148. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 150. Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 151. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 152. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Major Business
Table 153. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 154. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 156. Emmi Chengxin Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 157. Emmi Chengxin Biopharmaceutical Co., Ltd Major Business
Table 158. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product and Services
Table 159. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 160. Inactivated Influenza Virus Vaccine Raw Material
Table 161. Key Manufacturers of Inactivated Influenza Virus Vaccine Raw Materials
Table 162. Inactivated Influenza Virus Vaccine Typical Distributors
Table 163. Inactivated Influenza Virus Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Inactivated Influenza Virus Vaccine Picture
Figure 2. World Inactivated Influenza Virus Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Inactivated Influenza Virus Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Inactivated Influenza Virus Vaccine Production (2017-2028) & (K Units)
Figure 5. World Inactivated Influenza Virus Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Inactivated Influenza Virus Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Inactivated Influenza Virus Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Inactivated Influenza Virus Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Inactivated Influenza Virus Vaccine Production (2017-2028) & (K Units)
Figure 10. China Inactivated Influenza Virus Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Inactivated Influenza Virus Vaccine Production (2017-2028) & (K Units)
Figure 12. Inactivated Influenza Virus Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Inactivated Influenza Virus Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Inactivated Influenza Virus Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Inactivated Influenza Virus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Influenza Virus Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Influenza Virus Vaccine Markets in 2021
Figure 26. United States VS China: Inactivated Influenza Virus Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Inactivated Influenza Virus Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Inactivated Influenza Virus Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Inactivated Influenza Virus Vaccine in United States
Figure 30. Key Producers and Market Share of Inactivated Influenza Virus Vaccine in China
Figure 31. Key Producers and Market Share of Inactivated Influenza Virus Vaccine in Rest of World
Figure 32. World Inactivated Influenza Virus Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Inactivated Influenza Virus Vaccine Production Value Market Share by Type in 2021
Figure 34. Whole Virus Vaccine
Figure 35. Subunit Vaccine
Figure 36. World Inactivated Influenza Virus Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Inactivated Influenza Virus Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Inactivated Influenza Virus Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Inactivated Influenza Virus Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Inactivated Influenza Virus Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Inactivated Influenza Virus Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Inactivated Influenza Virus Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Inactivated Influenza Virus Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Inactivated Influenza Virus Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Inactivated Influenza Virus Vaccine
Figure 48. Inactivated Influenza Virus Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Inactivated Influenza Virus Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Inactivated Influenza Virus Vaccine Picture
Figure 2. World Inactivated Influenza Virus Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Inactivated Influenza Virus Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Inactivated Influenza Virus Vaccine Production (2017-2028) & (K Units)
Figure 5. World Inactivated Influenza Virus Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Inactivated Influenza Virus Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Inactivated Influenza Virus Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Inactivated Influenza Virus Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Inactivated Influenza Virus Vaccine Production (2017-2028) & (K Units)
Figure 10. China Inactivated Influenza Virus Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Inactivated Influenza Virus Vaccine Production (2017-2028) & (K Units)
Figure 12. Inactivated Influenza Virus Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Inactivated Influenza Virus Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Inactivated Influenza Virus Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Inactivated Influenza Virus Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Inactivated Influenza Virus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Influenza Virus Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Influenza Virus Vaccine Markets in 2021
Figure 26. United States VS China: Inactivated Influenza Virus Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Inactivated Influenza Virus Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Inactivated Influenza Virus Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Inactivated Influenza Virus Vaccine in United States
Figure 30. Key Producers and Market Share of Inactivated Influenza Virus Vaccine in China
Figure 31. Key Producers and Market Share of Inactivated Influenza Virus Vaccine in Rest of World
Figure 32. World Inactivated Influenza Virus Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Inactivated Influenza Virus Vaccine Production Value Market Share by Type in 2021
Figure 34. Whole Virus Vaccine
Figure 35. Subunit Vaccine
Figure 36. World Inactivated Influenza Virus Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Inactivated Influenza Virus Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Inactivated Influenza Virus Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Inactivated Influenza Virus Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Inactivated Influenza Virus Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Inactivated Influenza Virus Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Inactivated Influenza Virus Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Inactivated Influenza Virus Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Inactivated Influenza Virus Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Inactivated Influenza Virus Vaccine
Figure 48. Inactivated Influenza Virus Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Inactivated Influenza Virus Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
